PONDEL, K.; KAWAŁKO, K.; BIELEWICZ, K.; CHMURA, A.; KARAŚ, A. Effect of glucagon-like peptide-1 (GLP-1) agonists on the example of semaglutide on the cardiovascular system and their role in the treatment of obesity. Journal of Education, Health and Sport, [S. l.], v. 12, n. 9, p. 55–60, 2022. DOI: 10.12775/JEHS.2022.12.09.007. Disponível em: https://apcz.umk.pl/JEHS/article/view/39508. Acesso em: 26 apr. 2024.